Can repeated plasma donation by asymptomatic HIV-infected individuals delay the onset of AIDS?

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 352, Issue 1355, 1997, Pages 763-770

  Bainbridge, D R ^a,d   Lowdell, M W ^a,e   Hannet, I M ^c   Strauss, K W ^c   Karpas, A ^b  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c Becton Dickinson France   (Belgium)

^d Alderford House   (United Kingdom)

^e ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0031590049     PISSN: 09628436     EISSN: None     Source Type: Journal    
DOI: 10.1098/rstb.1997.0060     Document Type: Article

References (35)

1. Aledort, L. M., Hilgartner, M. W., Pike, M. G., Gjerset, G. F., Koerper, M. A., Lian, E. Y. C., Lusher, J. M. & Mosley.J. W. 1992 Variability in serial CD4 counts and relation to progression of infection to AIDS in haemophiliac patients. Br. Med. J. 304, 212-216.
2. Centers for Disease Control and Prevention 1993 Revised classification system for HIV and expanded surveillance case definition for AIDS among adolescents and adults. J. Am. Med. Ass. 269(6), 729-730.
3. + T lymphocytemediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism. AIDS Res. Hum. Retrov. 9(11), 1079-1086.
4. + lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine. Ann. Intern. Med. 118, 674-680.
5. Concorde Coordinating Committee 1994 Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet 343, 871-881.
6. Coffin, J. M. 1995 HIV population dynamics in vivo: implications for genetic variation, pathogenesis and therapy. Science 267, 483-489.
7. Cummins, L. M., Weinhold, K.J., Matthews, T. J., Langlois, A.J., Perno, G. F., Condie, R. M., Allain, J.-P. 1991 Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virusseropositive donors. Blood 77(5), 1111-1117.
8. + cell numbers reflects increase in HIV-1 replication. AIDS Res. Hum. Retrov. 4(6), 433-440.
9. Easterbrook, P.J., Emami,J. & Gazzard, B. 1993 Rate of CD4 cell decline and prediction of survival in zidovudinetreated patients. AIDS 7, 959-967.
10. Ellenberg, S. 1993 Surrogate end-points in clinical trials. Br. Med. J. 302, 63-64.
11. Erkeller-Yuksel, F. M., Deneys, V., Yuksel, B., Hannet, I., Hulstaert, F., Hamilton, C., Mackinnon, H., Turner Stokes, L., Munhyeshuli, V., Vanlangendonck, F., De Bruyere, M., Bach, B. A. & Lydyard, P. M. 1992 Age-related changes in human blood lymphocyte subpopulations. J. Pediat. 120(2), 216-222.
12. + lymphocyte activity. J. Infect. Dis. 172, 329-339.
13. Freeman, G. H. & Halton, J. H. 1951 Note on an exact treatment of contingency, goodness of fit and other problems of contingence.Biometrika 38, 141-149.
14. + lymphocyte response to zidovudine as a predictor of AIDS-free time and survival time. J. AIDS 6, 1258-1266.
15. Hulstaert, F., Hannet, I., Deneys, V., Munhyeshuli, V., Reichert, T., De Bruyere, M. & Strauss, K. 1994 Agerelated changes in human blood lymphocyte subpopulations. II. Varying kinetics of percentage and absolute count measurements. Clin. Immunol. Immunopathol. 70, 152-158.
16. Karpas, A., Gillson, W., Bevan, P. C. & Oates, J. K. 1985 Lytic infection by British AIDS virus and development of a rapid cell test for antiviral antibodies. Lancet 2, 695-696.
17. Karpas, A., Hill, F., Youle, M., Cullen, V., Gray,J., Byrom, N., Hayoe, F.,Tenant-Flowers, M., Howard, L., Gilgen, D., Oates, J. K., Hawkins, D. & Gazzard, B. 1988 Effects of passive immunisation in patients with the acquired immune deficiency syndrome-related complex and acquired immune deficiency syndrome. Proc. Natn. Acad. Sci. USA 85, 9234-9237.
18. Karpas, A., Hewlett, I. K., Hill, F., Gray, J., Byrom, N., Gilgen, D., Bally, V., Oates, J. K., Gazzard, B. & Epstein, J. E. 1990a Polymerase chain reaction evidence for human immunodeficiency virus-1 neutralization by passive immunisation in patients with AIDS and AIDS-related complex. Proc. Natn. Acad. Sci. USA 87, 7613-7617.
19. Karpas, A., Gray, J., Byrom, N., Gilgen, D., Bally, V., Oates, J. K. & Gazzard, B. 1990b Passive immunization in ARC and AIDS. Biotherapy 2, 159-172.
20. + suppressor T cells with human immnunodeficiency virus (HlV)-specific cellular cytotoxicity and natural killer activity in HIV infection. Immunology 74(4), 567-571.
21. Levacher, M., Hulstaert, F., Tallet, S., Ullery, S., Pocidalo, J.J. & Bach, B. 1992 The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value. Clin. Exp. Immunol. 90, 376-382.
22. Levy, J., Youvan, T., Lee, M. L., & the Passive Hyperimmune Therapy Study Group 1994 Passive hyper-immune plasma therapy in the treatment of acquired immnuodeficiency syndrome: results of a 12-month multi-center double-blind controlled trial. Blood 84(7), 2130-2135.
23. + cell antiviral factor. Cell Immunol. 153, 329-343.
24. Mihailov, C., Lamour, A., Beaudre-Bellein, V., Jezequel, N., Garre, M., Mottier, D., Guillet.G. & Youinou, P. 1993 Prognostic significance of cytotoxic T cells in individuals with human immunodeficiency virus. J. Clin. Immunol. 13(2), 139-144.
25. Moss, A. R., Bacchetti, P., Osmond, D., Krampf, W., Chaisson, R. E., Stites, D., Wilber, J., Allain, J. P. & Carlson.J. 1988 Seropositivity for HIV and development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. Br. Med. J. 296, 745-750.
26. Munoz, A., Carey, V., Saah, A.J., Phair, J. P., Kingsley, L. A., Fahey, J. L., Ginzburg, H. M., Polk, B. F. & the Multicenter AIDS Cohort Study 1988 Predictors of decline in CD4 lymphocytes in a cohort of homosexual men infected with human immunodeficiency virus. J. AIDS 1, 396-404.
27. Phillips, A., Lee, C. A., Elford, J., Janossy, G., Bofill, M., Timms, A. & Kernoff, P. B. A. 1989 Prediction of progression to AIDS by analysis of CD4 lymphocyte counts in a haemophilic cohort. AIDS 3, 737-741.
28. Phillips, A. N., Lee, C. A., Elford, J., Janossy, G., Timms, A., Bofill, M. & Kernoff, P. B. A. 1991 Serial CD4 lymphocyte counts and the development of AIDS. Lancet 337, 389-392.
29. Quint, L., Autran, B., Guillon, J. M., Parrot, A., Denis, M., Debre, P., Mayaud, C. M. & Akoun, G. M. 1992 Alveolites lymphocytaires aux stades precoces de l'infection par le VIH: correlations avec les facteurs biologiques de pronostic. Revue Maladies Réspiratoires 9(2), 155-162.
30. + T-cell levels. AIDS 7, 1159-1166.
31. Stricker, R. B., Youvan, T. D., McGrath, M. F. & Levy, J. 1995 Potential benefit of repeated plasma donation in asymptomatic HIV-infected individuals with decreased CD4 T-cell counts. J. Invest. Med. 43, 250A.
32. Vittecoq, D., Mattlinger, B., Barré-Sinoussi, F., Couroucé, A. M., Rouzioux, G., Doinel, C., Bary, M., Viard, J. P., Bach, J. F., Rouger, P. & Lefrère, J. J. 1992 Passive immunotherapy in AIDS: a randomized trial of serial human immunodeficiency virus-positive transfusions of plasma rich in p24 antibody versus transfusions off seronegative plasma. J. Infect. Dis. 165, 364-368.
33. Vittecoq, D., Morand-Joubert, L., Chevret, S., Heshmati, F., Audat, F., Bary, M., Dusatoir, T., Bismuth, A., Viard, J. P., Barré-Sinoussi, F., Bach, J. F., Lefrère, J. J. 1995 Passive immunotherapy in AIDS: a double blind randomized study based on transfusions of plasma rich in antibodies against HIV-1 versus transfusions of seronegative plasma. Proc. Natn. Acad. Sci. USA 92, 1195.
34. + lymphocytes can control HIV infection in vitro by supressing virus replication. Science 234, 1563-1566.
35. + cells varies among infected individuals. Cell Immunol. 119(2), 470-175.